Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
28.34
-0.19 (-0.67%)
Jul 21, 2026, 10:46 AM EDT - Market open
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $48 | Buy | Reiterates | $48 | +69.37% | Jul 15, 2026 |
| Wedbush | Wedbush | Hold Reiterates $26 → $30 | Hold | Reiterates | $26 → $30 | +5.86% | Jul 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +41.14% | Jul 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $72 | Buy | Maintains | $72 | +154.06% | Jul 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $79 | Buy | Maintains | $79 | +178.76% | Jun 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $84 → $96 | Buy | Reiterates | $84 → $96 | +238.74% | May 21, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $34 → $33 | Buy | Maintains | $34 → $33 | +16.44% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +76.43% | May 11, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.